Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...

Zydus Group | Photo Credit: Srikrishnan P C@Chennai Zydus Lifesciences Limited (“Zydus”) has entered into exclusive negotiations to purchase a controlling 85.6 percent stake in France-based ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

This new approval is one more milestone for Zydus Group, which has now received 420 USFDA approvals. As of now, the company has made 483 Abbreviated New Drug Applications (ANDAs), having started its ...

Zydus MedTech is focusing on high quality products ... Olivier Jallabert of a portion of his proceeds into the Amplitude group, as well as the absence of qualified material adverse events.

Zydus Lifesciences in talks to acquire majority stake in Amplitude Surgical for €256.8 million, aiming for growth opportunities in MedTech.

Zydus Lifesciences will acquire a majority stake in Amplitude Surgical, a European MedTech leader in lower-limb orthopaedic technologies, for €256.8 million. The acquisition will expand Zydus's ...

Zydus Lifesciences Group so far has filed 483 ANDAs and holds 420 approvals since the commencement of the filing process in FY 2003-04. The company reported a net profit of ₹1,023 Crore in the ...

in Ahmedabad and is being marketed by Zydus Vaxxicare - a division of the group focussing on preventives. “A quadrivalent vaccine, by covering strains of both influenza A and influenza B ...

Wondering how the vaccine works? Here's all you need to know. Zydus Cadila will seek nod for ZyCoV-D trial on 3-12 age group within 10 days: MD Sharvil Patel When asked about side effects of the ...